Search

Author/Creator Lanigan, Thomas M.

1. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis. Issue 8 (21st June 2019)

Authors:
Ohara, Ray A.; Edhayan, Gautam; Rasmussen, Stephanie M.; Isozaki, Takeo; Remmer, Henriette A.; Lanigan, Thomas M.; Campbell, Phillip L.; Urquhart, Andrew G.; Lawton, Jeffrey N.; Chung, Kevin C.; Fox, David A.; Ruth, Jeffrey H.
Journal:
Arthritis & rheumatology
Issue:
Volume 71:Issue 8(2019)
Page Start:
1241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis. Issue 9 (16th September 2021)

Authors:
Zupancic, Jennifer M.; Desai, Alec A.; Schardt, John S.; Pornnoppadol, Ghasidit; Makowski, Emily K.; Smith, Matthew D.; Kennedy, Andrew A.; Garcia de Mattos Barbosa, Mayara; Cascalho, Marilia; Lanigan, Thomas M.; Tai, Andrew W.; Tessier, Peter M.
Journal:
Cell chemical biology
Issue:
Volume 28:Issue 9(2021)
Page Start:
1379
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants. Issue 8 (2nd August 2021)

Authors:
Zupancic, Jennifer M.; Schardt, John S.; Desai, Alec A.; Makowski, Emily K.; Smith, Matthew D.; Pornnoppadol, Ghasidit; Garcia de Mattos Barbosa, Mayara; Cascalho, Marilia; Lanigan, Thomas M.; Tessier, Peter M.
Journal:
Advanced therapeutics
Issue:
Volume 4:Issue 8(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗